Financial Advocates Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,767
| Closed | -$306K | – | 762 |
|
|
2025
Q1 | $306K | Buy |
3,767
+68
| +2% | +$5.52K | 0.02% | 556 |
|
|
2024
Q4 | $333K | Sell |
3,699
-8,269
| -69% | -$745K | 0.02% | 570 |
|
|
2024
Q3 | $1.3M | Buy |
+11,968
| New | +$1.3M | 0.07% | 251 |
|
|
2024
Q2 | – | Sell |
-6,413
| Closed | -$605K | – | 799 |
|
|
2024
Q1 | $605K | Buy |
6,413
+798
| +14% | +$75.3K | 0.04% | 420 |
|
|
2023
Q4 | $534K | Buy |
5,615
+2,440
| +77% | +$232K | 0.03% | 417 |
|
|
2023
Q3 | $364K | Buy |
+3,175
| New | +$364K | 0.03% | 479 |
|
|
2023
Q1 | – | Sell |
-5,876
| Closed | -$488K | – | 818 |
|
|
2022
Q4 | $488K | Sell |
5,876
-3,580
| -38% | -$297K | 0.04% | 449 |
|
|
2022
Q3 | $585K | Buy |
9,456
+1,827
| +24% | +$113K | 0.05% | 370 |
|
|
2022
Q2 | $567K | Buy |
7,629
+1,148
| +18% | +$85.3K | 0.05% | 376 |
|
|
2022
Q1 | $582K | Buy |
+6,481
| New | +$582K | 0.04% | 409 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 798 |
|
|
2021
Q2 | – | Sell |
-3,284
| Closed | -$453K | – | 825 |
|
|
2021
Q1 | $453K | Sell |
3,284
-1,201
| -27% | -$166K | 0.03% | 491 |
|
|
2020
Q4 | $368K | Buy |
+4,485
| New | +$368K | 0.03% | 515 |
|